Background. Buffalo/Mna rats spontaneously develop a nephrotic syndrome (NS). We have demonstrated that this rat nephropathy recurs after renal transplantation. We studied this recurrence by kinetic analysis of graft lesions, infiltrating cells and cytokines. Methods. Kidneys from LEW.1W rats were grafted into proteinuric Buff/Mna or healthy Wistar Furth recipients. Kidney samples were harvested before, during and after the occurrence of proteinuria and analysed for renal histology, cell populations and cytokine transcripts. Results were compared with the evolution of the initial disease studied previously. Results. Both groups showed normal graft histology at Day 7 and an increasing podocyte swelling at Day 45 was seen only in the Buff/Mna recipients. At Day 80, glomerular atrophy with podocytosis and focal segmental glomerular sclerosis lesions, accompanied by tubular dilatation, appeared in the Buff/Mna group. At Day 122, the intensity of the tubular and glomerular lesions increased in Buff/Mna recipients but not in the control group. An analysis of desmin and Kim-1 (early markers of glomerular and tubular damage, respectively) transcripts expression showed that glomerular lesions precede tubular injury in this model. A monocyte infiltration associated with an increase in TNFα, IL1 and IL12 transcripts appeared before the recurrence. An early increase in Cbeta TCR transcripts with a predominant Th2 profile was observed, highlighting a Th2 polarization in the Buff/Mna recurrence. Conclusions. The comparison of profiles of recurrence and initial disease highlighted the same mediators for both events. We propose that initial Buff/Mna idiopathic nephrotic syndrome (INS) and post-transplantation recurrence represent the same entity and a valuable tool for the study of recurring INS.
Introduction
Idiopathic nephrotic syndrome (INS) with primary focal segmental glomerular sclerosis (FSGS) is a disease of unknown aetiology, the symptoms of which include selective proteinuria and characteristic but non-specific lesions with hyaline deposits and synechia formation between the glomerular tuft and Bowman's capsule. Recent progress has been made in the study of the pathophysiology of INS [1] . One group of patients has genetic abnormalities of genes involved in the slit diaphragm structure (i.e. podocin, nephrin and α-actinin-4, Ect), leading to a defect in the glomerular filtration barrier. These genetic forms of the disease are usually resistant to steroids and do not show recurrence after transplantation. A second group of patients has an 'immune', non-genetic form of the disease, and a large proportion of these patients have a disease that is sensitive to corticosteroids. However, 20% of these patients show a resistance to current immunosuppressive drugs (corticosteroids, cyclosporin A or cyclophosphamide) and evolve to end-stage renal failure, requiring substitutive therapy like dialysis and/or transplantation. Ultimately, 50% of these patients display an immediate recurrence of proteinuria after kidney transplantation, which is highly suggestive of the presence of a plasmatic factor with the ability to alter glomerular permselectivity [2] . This later subgroup of patients is considered to have an immunological form of INS, the pathological mechanisms of which remain unknown.
Although several animal models of INS/FSGS have been described [3] [4] [5] [6] , the majority are models of secondary INS/FSGS. These models can help to identify the mechanisms involved in glomerular sclerosis progression, but they do not represent a causal model in which a putative permeability factor could be involved. For this reason, we studied the Buffalo/Mna (Buff/Mna) rat strain, which develops a spontaneous glomerulonephritis at 2-3 months of age with selective proteinuria associated with hypoalbuminaemia, hyperlipidaemia and glomerular epithelial cell alterations with foot process flattening and cytoplasmic vacuolization at the ultrastructural level [7, 8] . Throughout this process, the animals remained normotensive and non-uraemic. At the initiation of proteinuria, only diffuse foot process effacement was observed, with FSGS lesions appearing later at 4-6 months of age [8] . The Buff/Mna rats were first described because of the presence of a spontaneous thymoma [9] associated with muscular weakness, which was linked to the presence of plasmatic anti-ryanodine receptor antibodies [10] . Two autosomal recessive genes were proposed to determine the susceptibility to glomerular sclerotic lesions by analysis of genetic segregation [11] . One locus was identified as Pur1 and is syntenic to the long arm of chromosome 1 in humans (which contains the NPSH2 gene) [12] . Recently, the Arp3 gene from the Pur1 region was found to be mutated in Buff/Mna rats compared with four other rat strains. This gene encodes for a protein of the Arp2/3 complex that is responsible for the nucleation of actin in a branched actin network in response to signalling for cell motility. A mislocalization of Arp3 and F-actin is visible in the glomeruli of Buff/Mna rats >6 months of age [13] .
By experiments of neonatal thymectomy, nephrotic syndrome has been shown to be functionally unrelated to the thymic disease [14] . In addition to a genetic defect in the actin cytoskeleton, which could explain in part a susceptibility to develop a glomerulopathy [11] [12] [13] , we have suggested the involvement of an extra-renal factor in this model in a previous study [15] . Through transplantation experiments, we indeed demonstrated the recurrence of the initial disease after transplantation of normal rat kidneys into Buff/Mna recipients and its remission when nephrotic Buff/Mna kidneys were transplanted into healthy rats [15] . We have also highlighted the involvement of activated macrophages and Th2 lymphocytes in this disease [16] .
In this report, we studied the kinetics of the posttransplantation recurrence of the Buff/Mna nephropathy. We compared the histological lesions, the cell infiltrates and the cytokine transcript accumulation in the grafted kidneys and in the native Buff/Mna kidneys. Our results showed similar timing and mediators in the events, demonstrating that the post-transplantation recurrence and the initial Buff/Mna disease are the same pathological entity. Such observations may also be used as a tool to elucidate the human pathological mechanisms involved in some cases of INS.
Materials and methods

Animals and measurement of proteinuria
The Buffalo/Mna rat strain maintained in our laboratory was originally kindly provided by Dr Saito (Central Experimental Institute, Nokawa, Kawasaki, Japan). All animals were born from a unique couple and bred for at least 10 generations. The animal care involved in this study was in accordance with our institutional guidelines. The animals were placed in metabolic cages for 24 h. The total urinary protein concentration (g/L) was measured by a colorimetric method using a Hitachi autoanalyser (Behringer), and the urinary creatinine (mmol/L) was measured by the Jaffé method. Proteinuria was expressed according to the following formula: proteinuria (g/mmol) = urinary proteins (g/L)/urinary creatinine (mmol/L). The level of proteinuria was considered abnormal when it reaches >0.2 g/mmol.
Renal transplantation
Healthy rat kidneys (LEW.1W; RT1 u ; 250-300 g) were transplanted into proteinuric Buff/Mna recipients (RT1 u ; 5 months of age; 250-300 g) (n = 15) or unproteinuric Wistar Furth (WF) rats (RT1 u ; 250 g) (n = 15). Rats were anaesthetized for~90 min by isofluorane/oxygen inhalation. The surgical technique has been described elsewhere [17] . The first nephrectomy was performed during the transplantation procedure and the second nephrectomy 7 days later. All recipients (Buff/Mna or WF) received a donor-specific transfusion (1 mL of donor blood injected intravenously 14 and 7 days before transplantation; [18] ) to avoid potential host anti-donor minor rejection elements (see [15] ). Kidney graft samples (n = 5 in each group) were harvested at Day 7, at Day 45 just before the onset of the proteinuria and at Days 80 and 122 when rats (in the Buff/Mna group) were overtly proteinuric and the two groups were histologically clearly distinct (see Table 2 ). For complement, see [15] for details on the Day 122 animals and a brief comment on two animals at Days 45 and 80.
Light-microscopic examination
The light-microscopic preparation has been described previously [16] . Briefly, kidney biopsies were fixed for 20 min in Carnoy solution and then in 10% buffered formalin and embedded in paraffin. Three-micrometre sections were stained with haematoxylin and eosin, periodic acid Schiff, Masson trichrome and periodic acid-silver methenamine. All histological parameters (interstitial infiltrate, tubular dilatation, injured glomeruli) were analysed in a blinded fashion. Lesions were estimated on five fields at ×100 magnification [(number of injured glomeruli/total number of glomeruli) × 100] and as absolute number of dilated tubes (arbitrary units, AU). Only the glomeruli with typical FSGS lesions [i.e. segmental lesions of glomerular tuft, sclerotic area (±extensive) and flocculo-capsular synechia] were counted, with podocyte swelling (see at Day 45 in the Buff/Mna group) and podocytosis (very distinct at Day 80) being hard to quantify.
Real-time quantitative RT-PCR
Total RNA was prepared from the decapsulated kidneys of each animal by TRIzol extraction (Invitrogen). Messenger RNA was reverse transcribed as previously described [16] . cDNA (10 μL of 1/10-diluted sample) were amplified in 25 μL of SYBR Green® PCR Core Reagent (Applied Biosystems) with 0.6 U of AmpliTaq Gold polymerase, 0.25 U of Amperase uracyl-H-glycosylase, 200 nM of each dNTP and 3 mM of MgCl 2 in 10× SYBR Green® PCR buffer (1× final concentration). Rat primers (Table 1) were used at 300 nM each. Amplifications were performed in an ABI Prism® 7700 Sequence Detector (TaqMan, Perkin-Elmer). Each sample was analysed in duplicate. The number of copies of the cDNA target sequence was deduced from a comparison of the measured fluorescence with the standard curve (serial dilution from 10 7 to 10 2 copies per well of a construct standard, 1). Data were normalized to HPRT levels and expressed as ratio of gene of interest on HPRT (arbitrary units).
Quantitative analysis of cellular infiltrates
Immunohistology on the kidney slides of grafted Buff/Mna and WF rats were performed and the cell-infiltrated area was determined by quantitative morphometric analysis, as described previously [16] . Briefly, positively stained cells in each section were counted by morphometric analysis using a point counting method with a 121-intersection square grid in the eyepiece of the microscope. Results were expressed as the percentage of the area of each renal section occupied by cells of a particular antigenic specificity (±SD). The percentage of area infiltrate was calculated as follows: [(number of positive cells under grid intersections)/(total number of grid intersections = 121)] × 100. The sections were examined at a magnification of ×400. The accuracy of the technique is proportional to the number of points counted. Therefore, 15 fields were counted for each labelled section of high density and 40 fields for sections of low density (<10%). We chose a random start point on a border of a section and moved to field in field. Each counted field was adjacent to the previous and next fields. Counting was scored in a blinded fashion by two observers.
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C4d deposition was performed similarly with an affinity-purified polyclonal rabbit antibody against C4d, which was kindly provided by K. Murata (Department of Pathology, John Hopkins Medical Institution, Baltimore, USA) and used at a 1/1000 dilution.
Desmin staining was performed with a monoclonal mouse anti-rat desmin antibody (DE-U-10 clone, 1/20 dilution; Sigma Aldrich), then a biotinylated anti-mouse Ig (1/200; Vector Laboratories, Burlingame, CA, USA) and then a streptavidin peroxidase (1/1000, Vector Laboratories) revealed by the VIP substrate (Vector Laboratories).
Statistical analysis
Statistical analysis was performed using GraphPad Prism software. The Mann-Whitney test was used to compare the histological data in Table 2 and transcript levels in Figures 2, 3 , 4, 5 and 6. A Friedman test followed by Dunn's multiple tests were used to compare levels of desmin and Kim-1 transcripts in Figure 7 . P < 0.05 was considered to be significant.
Results
Histological examination of kidney transplants during the Buff/Mna post-transplantation recurrence
At every time point in both groups, no lesion representing acute rejection (tubulitis or vascular damage) was observed. Only slight interstitial oedema with a lymphocyte infiltrate of variable abundance was observed in some animals. C4d deposition was also assessed to check the presence of acute antibody-mediated rejection, and we found no peritubular vascular staining (data not shown).
At Day 7 after transplantation in both groups, the renal parenchyma was normal with some rare dilated tubes IL1a  AGTCACTCGCATGGCATGTG  ATATGTCGGGCTGGTTCCAC  IL2  CCTTGTCAACAGCGCACCC  GCTTTGACAGATGGCTATCC  IL4  CCACCTTGCTGTCACCCTGT  AGGATGCTTTTTAGGCTTTC  IL6  CAAAGCCAGAGTCATTCAGAGC  GGTCCTTAGCCACTCCTTCTGT  IL10  TCAGCACTGCTATGTTGCC  CCTTGCTTTTATTCTCACAGG  IL12p40  GAAACAGTGAACCTCACCTG  TGCTTCACACTTCAGGAAAGT  IL13  AGCAACATCACACAAGACCAG  CACAACTGAGGTCCACAGCT  IFNγ  TGGATGCTATGGAAGGAAAGA  GATTCTGGTGACAGCTGGTG  TGFβ  CTACTGCTTCAGCTCCACAGAGA  ACCTTGGGCTTGCGACC  Cβ  TCTGTGCTGACCCCATTGC  TTCCCTGACCATGTGGAGCT  TNFα CTTATCTACTCCCAGGTTCTCTTCAA GAGACTCCTCCCAGGTACATGG Desmin GTGGAGCGTGACAACCTGATAG TCAGTTGGATTTCCTCCTGTAGCT Kim-1 TGGCACTGTGACATCCTCAGA GCAACGGACATGCCAACATA Slides were examined by an independent pathologist in a blinded fashion. Lesions were estimated and counted in five fields at ×100 magnification. Five series of samples were examined. Results were expressed as mean ± SEM. Under the term 'damaged glomeruli', we counted all glomeruli with focal segmental glomerulosclerosis (FSGS) lesions (i.e. segmental lesions of glomerular tuft, sclerotic areas, flocculo-capsular synechia or atrophic glomeruli). P <0.05 was considered significant. a The second part of this table (Initial disease) reports results described in [16] .
Development of initial INS and post-transplantation recurrence(3 ± 2.4 AU in the Buff/Mna group vs 2.4 ± 1 AU in the WF group; P = ns). The glomeruli showed a modest podocyte swelling, particularly in Buff/Mna recipients, without lesions of podocytosis (primary lesion of podocytes defined by cell swelling, vacuolization and the presence of lipid droplets). Only a few glomeruli showed lesions of focal and segmental glomerulosclerosis (3.3 ± 1.4 vs 2.8 ± 0.9% in the Buff/Mna and WF groups, respectively; P = ns). At Day 45, the graft lesions of WF recipients remained almost the same as at the previous time point. A modest mesangial hyperplasia with an increase of podocyte swelling (in comparison with Day 7) was observed in the Buff/ Mna group, but the number of damaged FSGS glomeruli was not significantly increased at this stage (3.8 ± 0.65 vs 2.5 ± 2% in the WF group, P = ns). Nevertheless, the glomerular lesions spread into the glomeruli in the Buff/ Mna group. Occasional tubular dilatation was present (5.2 ± 2 vs 1.75 ± 1.7 AU in the Buff/Mna and WF groups, respectively; P = ns).
At Day 80, morphological differences between the two groups became evident (Figure 1 ). Glomerular atrophy, an increase in mesangial hyperplasia and development of lesions of podocytosis were observed in the Buff/Mna recipients group. Glomerular lesions were diffused and spread into the glomerular tuft. Nevertheless, at this stage, classic FSGS lesions remained rare, but they were increased in number (5.05 ± 0.7 vs 1.75 ± 0.5% in the WF group, P = 0.016). A marked corticomedullary dilatation of tubes was displayed and was characteristic of Buff/Mna group (23.2 ± 6.7 vs 3.2 ± 1.16 AU in the WF group, P = 0.016; Figure 1 ). At Day 80, no modification of the stable and minor lesions described at Days 7 and 45 were observed in the WF group. Finally, at Day 122 when the recurrence was well established (see [15] ), samples from the Buff/Mna group exhibited an increase in the number of FSGS glomeruli with destroyed flocculi and an increase in sclerotic areas in the glomeruli and of global glomerular atrophy. Tubular dilatations continued to expand and became microcystic [15] . No features of collapsing glomerulopathy were found at any time of the kinetics.
Quantitative assessment of post-transplantation kidney infiltration
We then accurately analysed renal graft cell infiltration by a quantitative immunochemistry method. The kidneys transplanted into Buff/Mna recipients displayed an overall but moderate increase in their total leukocyte population during recurrence of the disease. These values were significantly different from those of kidneys grafted into WF recipients at Days 45, 80 and 122 (12.5 ± 0.4 vs 9.66 ± 0.5%, 18.5 ± 1.4 vs 10.7 ± 0.3% and 14.6 ± 0.4 vs 12.2 ± 0.3%, respectively; P < 0.05) (Figure 2a) . In particular, the number of monocytes and macrophages was significantly higher (P < 0.05) in Buff/Mna recipients than in control WF recipients at Day 7 (4.1 ± 0.2 vs 2.4 ± 0.15%), Day 45 (5.2 ± 0.3 vs 3.3 ± 0.2%) and Day 80 (5.3 ± 0.17 vs 3.17 ± 0.16%) (Figure 2b ). T cells were also increased in the Buff/Mna kidneys and were significantly more represented than in control kidneys from Day 45 to Day 122 (6.8 ± 0.3 vs 4.24 ± 0.3%, 9.4 ± 0.9 vs 4.34 ± 0.18% and 7.1 ± 0.5 vs 4.9 ± 0.3%, respectively; P < 0.05; Figure 2c ). The level of B lymphocytes did not significantly differ between Buff/Mna and control rats, except at Day 45 when it was increased in the Buff/Mna group (1.96 ± 0.3 vs 0.56 ± 0.02%, P < 0.05) (data not shown). Quantitative analysis of mRNA transcripts in transplanted kidneys during post-transplantation recurrence in Buff/ Mna rats Monocyte-associated cytokine transcripts. Tumor necrosis factor α (TNFα) mRNA showed an early and significant accumulation in kidneys grafted into Buff/Mna rats before the onset of proteinuria [Day 7: 0.51 ± 0.08 vs 0.09 ± 0.04 AU for the control group (WF); Day 45: 0.44 ± 0.11 vs 0.16 ± 0.02 AU; P < 0.05; (Figure 3) ], and the difference became non-significant when the proteinuria is installed. IL1 transcripts were also significantly increased at Day 45 (0.66 ± 0.4 in the Buff/Mna group vs 0.05 ± 0.01 AU in the control group, P < 0.05; Figure 3 ). IL12 mRNA was significantly elevated at Day 7 [0.07 ± 0.01 in the Buff/Mna group vs 0.0004 ± 0.0002 AU in the control group, P < 0.05; (Figure 3)] . Surprisingly, we observed a decrease in this expression at Day 45 [0.001 ± 0.00008 in the Buff/ Mna group vs 0.019 ± 0.005 AU in the control group, P < 0.05; (Figure 3) ] perhaps due to regulatory mechanisms of inflammation, which can down-regulate these types of cytokines (like IL1), leading to avoidance of their side effects. IL6 transcripts were not significantly increased in comparison to the healthy group (P = ns, data not shown). Accumulation of these transcripts decreased after the onset of proteinuria and was low at Day 122.
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T-lymphocyte-associated cytokine transcripts. The quantification of the constant part of TCR β chain transcripts (Cβ) permitted us to observe an activation of T lymphocytes at Day 7. Indeed, Cβ mRNA showed a strong accumulation at Day 7 (2.55 ± 0.9 vs 0.083 ± 0.02 AU in the control group, P < 0.05), whereas the T subset was scarcely represented at this stage ( Figure 3) . However, Cβ transcripts remained at low levels after (P = ns) ( Figure 4 ). The activation profile of the T cells present in the kidney during the development of the recurrence was then measured for Th1 (IL2 and IFN) and Th2 cytokine transcripts (IL4, IL10 and IL13). IL2 mRNA was significantly downregulated at Day 7 in the Buff/Mna kidneys (0.008 ± 0.005 vs 0.14 ± 0.09 AU in the control group, P < 0.05; data not shown) and was not, like IFNγ mRNA, significantly different from the control group thereafter, indicating no Th1 polarization during the recurrence. In contrast, particularly at Day 45, Th2-related IL10 and IL13 transcripts were expressed at significantly higher levels in the kidneys grafted into Buff/Mna recipients than in the control recipients (IL10: 0.0018 ± 0.001 vs 0.0003 ± 0.00001 AU, P < 0.05 and IL13: 0.056 ± 0.04 vs 0.004 ± 0.003 AU, P < 0.05) just before the onset of recurrence ( Figure 5) .
The IL4 mRNA level was at the technical limit of the SYBR Green® method and thus considered to be negligible in both groups.
Transforming growth factor β transcripts. TGFβ mRNA levels were low early on and even down-regulated before the recurrence (at Day 45: 0.007 ± 0.002 vs 5.6 ± 1.2 AU; P < 0.05), it then seemed to progressively increase in Buff/ Mna recipients, perhaps in parallel with development of Figure 7A ). The WF group did not show these variations in desmin expression and remained at a moderate level and inferior to Buff/Mna group at all stages ( Figure 7A ). In the same way, the Kim-1 mRNA amount in WF recipients group remained at low and stable level from D7 to D122 ( Figure 7A) .
Immunochemistry was performed to determine where the desmin staining is in the kidney. In kidneys of nontransplanted rats ( Figure 7B, panels a and b) , desmin was present essentially in glomeruli and vessels. This basal staining was found also in WF recipients at D7, D45, D80 and D122 after transplantation (panels d, f, h and j) with a light interstitial staining observed between tubules at D80 and D122. In the Buff/Mna recipients group, the same basal glomerular staining was noted at D7 and D45 (panels c and e). A more intense glomerular staining was observed in some glomeruli at D80 associated with a weak interstitial stain. At D122, desmin staining progressed essentially 
Discussion
We have previously demonstrated the recurrence of the initial glomerulopathy of Buff/Mna rats in MHC-compatible transplanted kidneys [15] . We have studied the renal immune events of post-transplantation recurrence and compared them with those of the Buff/Mna initial disease [16] . Events linked to the recurrence were different from those of acute or chronic rejection processes, and anatomopathological examination did not show vascular damage, tubulitis, splitting of glomerular basement membrane or a pathological C4d deposition.
Recurrence of the Buff/Mna nephropathy was associated with several abnormalities that occurred before the onset of proteinuria and establishment of the renal lesions. At early stages before the occurrence of the proteinuria (Days 7 and 45), the renal pattern was similar between the Buff/Mna recurrent group and the control group matched for histocompatibility. However, in the Buff/ Mna group, an increased swelling of glomerular epithelial cells accompanied with the beginning of mesangial hypertrophy was observed at Day 45, followed by classic FSGS lesions. At Day 80, when proteinuria was overtly established in Buff/Mna rats, while lesions remained few in WF recipients, lesions of podocytosis developed in Buff/ Mna recipients, glomeruli became atrophic and the percentage of FSGS glomeruli increased. These patterns were also found at Day 122. Another remarkable difference between the two groups was the rapid evolution of tubular dilatation in Buff/Mna recipients (see Table 2 ). These tubular dilatations were also characteristic of the initial nephropathy of Buff/Mna rats [16] . The sequence of pathological events, analysed by means of two early markers of glomerular and tubular damage (desmin and Kim-1), showed that glomerular lesions seem to precede tubular ones and can explain the occurrence of the tubular dilatation. Such tubular abnormalities have also been reported in humans, specifically in HIV patients with severe FSGS lesions [19] . Indeed, HIV FSGS nephropathy, which is associated with marked podocyte swelling, hypertrophy and collapsed glomeruli, also exhibits severe tubular microcystic dilatation. Buff/Mna rats may possess a similar predisposition to develop this form of FSGS with tubular lesions.
The minimal glomerular lesions observed in the WF recipients (at Days 7 and 45) were likely a result of an inflammatory process, the aftermath of the surgical procedure, and not specific for renal disease. These lesions did not evolve but rather tended to decrease with time, whereas Buff/Mna samples progressed clearly towards FSGS lesions.
Immunohistology showed that the most represented cell lineage in the kidney infiltrate before and during the development of the disease (Days 7, 45 and 80) was monocytes/ macrophages in Buff/Mna recipients. The number of T lymphocytes also rose before the beginning of recurrence (Figure 2 ). The renal infiltrate present during the recurrence of the Buff/Mna nephropathy was notably increased compared with the initial disease (5-18 vs 4-6%, respectively), likely because of the addition of an inflammatory process due to the transplantation procedure (1, Table 2 ).
From a molecular standpoint, mediators involved in the early stages preceding the occurrence of the proteinuria (Day 7 and particularly Day 45) showed roughly the same profile as those found in the Buff/Mna initial disease (1, Table 3 ). This profile included an activation of T cells (strong up-regulation of the Cβ chain of TCR, with a weak increase in T-cell number) with an up-regulation of Th2 cytokines (despite a weak IL4 expression, well known in rats), accompanied by a down-regulation of Th1 cytokines. This Th2 profile is in agreement with recent reports showing that the Th2 profile predominates in INS [20, 21] , with a considerable rise in IL13 [22] [23] [24] and IL4 [24, 25] , and describes an association of INS with atopic phenomena [26, 27] and an abnormal isotypic switch [28] . Finally, a recent article showed that overexpression of IL13 in animals induces a minimal change-like nephropathy, suggesting again a possible role of this cytokine in INS [29] .
In accordance with the increase in monocytic infiltrate, we also observed an increase in monocyte-associated cytokines like TNFα, IL1 and IL12 before the occurrence of the disease (Days 7 and 45), which indicated a profile of activated and secreting monocytes. In humans, TNFα has been reported to be increased in the blood and urine of FSGS patients [30, 31] , and TNFα mRNA levels were elevated in the monocytes of these patients [31] . TNFα has also been found to be increased in monocyte supernatants in puromycin aminonucleoside nephropathy [32] , and the injection of TNFα into rats can trigger glomerular injury [33, 34] . In the same manner, an increase in IL12 production by the monocytes of INS patients has also been described [35] , and IL6 has been associated with glomerular damage in glomerulonephritis [36] . A role for macrophages that release these cytokines can thus be suspected in the onset of the Buff/Mna disease as well as in the puromycin model and in the human disease, in which they are called foam cells and have been shown to be present in the lesion area [37] . Recurrence in Buff/Mna rats is not as rapid as it is usually observed in human disease and does not suggest a primary effect of a circulating proteinuric factor. In humans, immediate occurrence of proteinuria is an unambiguous presentation of INS recurrence that is the basis for the 'plasmatic factor hypothesis', with the remission of proteinuria after plasma treatment. Nevertheless, some patients have been reported to show late recurrence, which in some cases is associated with a change in IS treatment [38] . One cannot exclude that additional cellular mechanisms which may require a time interval after transplantation to occur may also play a role in some patients. In addition, some patients show very late and progressive forms of recurrence, which might be entirely or in part controlled by their immunosuppressive treatment (state of pathological latency).
In addition, we have recently shown that this disease can improve and even regress after the transfer of CD4 + CD25 + T cells or following a treatment capable of inducing regulatory T cells in the periphery (LF15-0195, a derivative of deoxyspergualin; [39] ). This means that the immune cells involved similarly in the initial disease and the recurrence could be regulated, opening new therapeutic pathways. The specific effect of LF15-0195 treatment on the Buff/ Mna initial disease like the post-transplantation recurrence, not found on other models of nephropathy and with other immunosuppressive drugs [39] , is further evidence that they are the same biological entity. Taken together with and based on these observations, we reinforce the interest of Buff/Mna rats as a model of post-transplantation recurrent INS, and we suggest that this model may be useful for the study of INS mechanisms. Despite the lack of knowledge in the aetiology of the nephrotic syndrome in the human like in the Buff/Mna rat, this model can provide subjects of reflection for new therapeutic approaches.
